Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies.

Liu Z, Ma Y, Yang J, Qin H.

OMICS. 2011 Jan-Feb;15(1-2):61-71. doi: 10.1089/omi.2010.0061. Epub 2010 Aug 20. Review.

PMID:
20726783
2.

Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.

Li N, Long Y, Fan X, Liu H, Li C, Chen L, Wang Z.

J Exp Clin Cancer Res. 2009 Aug 28;28:122. doi: 10.1186/1756-9966-28-122.

3.

Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.

Wang RC, Huang CY, Pan TL, Chen WY, Ho CT, Liu TZ, Chang YJ.

PLoS One. 2015 Oct 2;10(10):e0139232. doi: 10.1371/journal.pone.0139232. eCollection 2015.

4.
6.

Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.

Orimo T, Ojima H, Hiraoka N, Saito S, Kosuge T, Kakisaka T, Yokoo H, Nakanishi K, Kamiyama T, Todo S, Hirohashi S, Kondo T.

Hepatology. 2008 Dec;48(6):1851-63. doi: 10.1002/hep.22552.

PMID:
18937283
7.

Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.

Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP.

J Proteome Res. 2005 Nov-Dec;4(6):2062-9.

PMID:
16335951
8.

Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.

Long J, Lang ZW, Wang HG, Wang TL, Wang BE, Liu SQ.

Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):296-305.

PMID:
20525558
9.

Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.

Sun Y, Mi W, Cai J, Ying W, Liu F, Lu H, Qiao Y, Jia W, Bi X, Lu N, Liu S, Qian X, Zhao X.

J Proteome Res. 2008 Sep;7(9):3847-59. doi: 10.1021/pr800153s. Epub 2008 Jul 23.

PMID:
18646787
10.

A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.

Reis H, P├╝tter C, Megger DA, Bracht T, Weber F, Hoffmann AC, Bertram S, Wohlschl├Ąger J, Hagemann S, Eisenacher M, Scherag A, Schlaak JF, Canbay A, Meyer HE, Sitek B, Baba HA.

Biochim Biophys Acta. 2015 Jun;1854(6):641-50. doi: 10.1016/j.bbapap.2014.10.024. Epub 2014 Nov 5.

PMID:
25448011
11.

Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.

Blanc JF, Lalanne C, Plomion C, Schmitter JM, Bathany K, Gion JM, Bioulac-Sage P, Balabaud C, Bonneu M, Rosenbaum J.

Proteomics. 2005 Sep;5(14):3778-89.

PMID:
16097030
12.

Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.

Nissom PM, Lo SL, Lo JC, Ong PF, Lim JW, Ou K, Liang RC, Seow TK, Chung MC.

FEBS Lett. 2006 Apr 17;580(9):2216-26. Epub 2006 Mar 20.

13.

Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma.

Junrong T, Huancheng Z, Feng H, Yi G, Xiaoqin Y, Zhengmao L, Hong Z, Jianying Z, Yin W, Yuanhang H, Jianlin Z, Longhua S, Guolin H.

J Biosci. 2011 Sep;36(4):659-68.

14.

Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.

Peng XQ, Wang F, Geng X, Zhang WM.

Expert Rev Proteomics. 2009 Oct;6(5):551-61. doi: 10.1586/epr.09.72. Review.

PMID:
19811076
15.

A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, Cole RN, Simmers J, Schulick RD, Singh S, Torbenson M, Pandey A, Thuluvath PJ.

J Proteome Res. 2008 Oct;7(10):4289-98. doi: 10.1021/pr800197z. Epub 2008 Aug 21.

16.

Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.

Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z, Mi W, Wu S, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F.

Mol Cell Proteomics. 2007 Oct;6(10):1798-808. Epub 2007 Jul 12.

17.

Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.

Yu MC, Lee YS, Lin SE, Wu HY, Chen TC, Lee WC, Chen MF, Tsai CN.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S455-63. doi: 10.1245/s10434-011-1946-2. Epub 2011 Aug 6.

PMID:
21822558
18.

Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.

Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W.

Dig Dis Sci. 2015 Nov;60(11):3351-63. doi: 10.1007/s10620-015-3774-x. Epub 2015 Jun 30.

PMID:
26123838
19.

Aberrant gene expression profiles in hepatocellular carcinoma detected by microdissection.

Wei YM, Li YY, Zhang YC, Nie YQ.

Genet Mol Res. 2013 Nov 18;12(4):5527-36. doi: 10.4238/2013.November.18.3.

20.

Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma.

Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Toda T, Sakaida I, Okita K, Oka M, Nakamura K.

Proteomics. 2003 Dec;3(12):2487-93.

PMID:
14673798

Supplemental Content

Support Center